Mutations in RB1 have been reported in the circulating tumor DNA (ctDNA) of several BC patients and in patient-derived tumor xenograft models (Herrera-Abreu et al. 2016; Condorelli et al. 2018; O'Leary et al. 2018). The gene discussed is RB1; the disease is neoplasm.